AzTrials
AzTrials

Multiple SclerosisNCT07366216

Chewing Under Dual-Tasking in MS

An observational study of Multiple Sclerosis, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate the effects of visual, auditory, and motor dual-task conditions on chewing performance in individuals with multiple sclerosis, compared with healthy controls. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Multiple Sclerosis
How many people
48 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Jan 2026to 1 Mar 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population consisted of individuals with multiple sclerosis and age-matched healthy controls.

Who may be able to join

  • Individuals aged between 18 and 65 years
  • Mini-Mental State Examination (MMSE) score of 24 or higher
  • Right-hand dominance

Who cannot join

  • Presence of visual and/or hearing impairment
  • Presence of difficulties in solid food intake and/or complaints related to mastication
  • Presence of neurological, psychological, cognitive, and/or chronic conditions that may affect mastication or chewing function
  • History of interventions affecting oral structure (e.g., oral/maxillofacial surgery or radiotherapy) within the last month
  • Known allergy to the food used in the test

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Seda Nur Kemer, PhD contact

+905467861866

sedakemer@gmail.com

Turkey (Türkiye)1 site
  • Ondokuz Mayis University

    Samsun

    Seda Nur Kemer, +905467861866, sedakemer@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Different Dual-Task Conditions on Chewing Function in Individuals With Multiple Sclerosis

This study aims to investigate the effects of visual, auditory, and motor dual-task conditions on chewing performance in individuals with multiple sclerosis, compared with healthy controls.

Medical subject headings
Multiple Sclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07366216
Study groupRoleWhat they receive
Multiple SclerosisNot described
Healthy ControlNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Test of Masticating and Swallowing Solids

    Test of Masticating and Swallowing Solids (TOMASS) is a standardized clinical assessment used to evaluate solid bolus mastication and swallowing performance.

    Measured: Baseline (single-task and dual-task conditions assessed on the same day)

  2. Mini-Mental State Examination (MMSE)

    The MMSE is a brief, widely used screening tool for assessing global cognitive function.

    Measured: Baseline

  3. Go/No-Go Test

    The Go/No-Go Test is a neuropsychological assessment used to evaluate response inhibition and sustained attention.

    Measured: Baseline (single-task and dual-task conditions assessed on the same day)

  4. Auditory Reaction Time Test

    The Auditory Reaction Time Test is used to assess auditory attention and the speed of motor response to auditory stimuli.

    Measured: Baseline (single-task and dual-task conditions assessed on the same day)

  5. Tap Tool

    The Tap Tool is a neuropsychological and motor performance assessment used to evaluate psychomotor speed and fine motor control.

    Measured: Baseline (single-task and dual-task conditions assessed on the same day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2026
  2. Study start26 Jan 2026 (estimated)
  3. Primary completion15 Feb 2026 (estimated)
  4. Study completion1 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07366216
Sponsor's protocol ID
1919B012411772
Status last verified
Jan 2026
First submitted
9 Jan 2026
Last updated
26 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Multiple Sclerosis, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Seda Nur Kemer, PhD (+905467861866, sedakemer@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Test of Masticating and Swallowing Solids (time frame: Baseline (single-task and dual-task conditions assessed on the same day)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Chewing Under Dual-Tasking in MS (NCT07366216) | AzTrials